Immune checkpoints in central nervous system autoimmunity
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Summary: A number of autoimmune diseases, including multiple sclerosis, are mediated by self‐reactive T cells that have escaped the deletional mechanisms of central tolerance. Usually, these T cells are kept at bay through peripheral tolerance mechanisms, including regulation through coinhibitory receptors and suppression by regulatory T cells. However, if these mechanisms fail, self‐reactive T cells are activated and autoimmune responses ensue. This review outlines how the coinhibitory receptors CTLA‐4 (cytotoxic T‐lymphocyte antigen‐4), PD‐1 (programed death‐1), Tim‐3 (T‐cell immunoglobulin‐ and mucin domain‐containing molecule 3), and TIGIT (T‐cell immunoreceptor with immunoglobulin and ITIM domains) act at different checkpoints to inhibit autoreactive T cells and suppress the development of central nervous system autoimmunity. Loss of each of these receptors predisposes to autoimmunity, indicating a non‐redundant role in maintaining peripheral tolerance. At the same time, their functional patterns seem to overlap to a large degree. Therefore, we propose that only the concerted action of a combination of inhibitory receptors is able to maintain peripheral tolerance and prevent autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“The discovery that the cytokine IL-23, which is important for the generation of IL-17-producing Th17 cells, is crucial for the development of autoimmunity (29, 32) shifted the focus toward Th17 cells.”
BackgroundWherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 3×
“IL-6 and TGF-b signals ultimately lead to the expression of the Th17 specific transcription factor RORct, which transactivates many Th17associated factors, including the signature cytokines IL-17A and IL-17F (45).”
BackgroundThe interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903474106 · Cited by 3,524 · cited 18×
“2012 John Wiley & Sons A/S 128 Immunological Reviews 248/2012 TIGIT TIGIT (also called Vsig9, Vstm3, or WUCAM) is a CD28 family protein composed of an extracellular IgV domain, a transmembrane domain, and a cytoplasmic tail containing two ITIM motifs (139–143).”
BackgroundInfluentialCTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956 · cited 2×
“Furthermore, CTLA-4 is instrumental in reducing the level of costimulatory B7 molecules on APCs, as the observed reduction of CD80 and CD86 on APCs conditioned by Tregs is abrogated in the presence of CTLA-4 blocking antibody or when CTLA-4 KO Tregs are used (19, 126, 127).”
BackgroundCua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906 · cited 2×
“lacking key Th1-associated factors, including the signature molecules IFN-c, IFN-cR, STAT1, and IL-12p35, are actually more susceptible to multiple autoimmune diseases, including EAE (26, 28, 29), experimental autoimmune uveitis (EAU; 30), and collagen-induced arthritis (CIA; 31).”
BackgroundLymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 2×
“Failure to keep T-cell responses in check causes excessive immune activation and autoimmunity, as exemplified in CTLA-4 knockout (KO) mice, which succumb to multi-organ autoimmune disease (12, 13).”
BackgroundNishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749 · cited 1×
“neously develop a lupus-like disease characterized by autoantibodies and a mild glomerulonephritis or cardiomyopathy, depending on the genetic background (164).”
BackgroundPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175 · cited 3×
“In mouse, autoimmunity is associated with the generation of liCTLA-4 (95), whereas in humans autoimmunity is associated with two SNPs (CT60 and +49G > A) where in both cases the protective A allele favors the generation of sCTLA-4 over the full-length protein (95).”
Background
Cited by
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
Shin, D. S., & Ribas, A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.006 · Cited by 346
Disease-specific molecular events in cortical multiple sclerosis lesions
Fischer, M. T., Wimmer, I., Höftberger, R., Gerlach, S., Haider, L., Zrzavy, T., Hametner, S., Mahad, D., Binder, C. J., Krumbholz, M., et al. (2013) · Brain · doi:10.1093/brain/awt110 · Cited by 311
“anti-inflammatory function of this molecule in patients with multiple sclerosis (Joller et al., 2012).”
BackgroundResultJie, H.-B., Gildener-Leapman, N., Li, J., Srivastava, R. M., Gibson, S. P., Whiteside, T. L., & Ferris, R. L. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.645 · Cited by 286
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation
Schwartz, M., & Deczkowska, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.08.001 · Cited by 246
“Therapy: immune checkpoint modulation Inducing suppressive immune checkpoint function [18] (immune suppression) Inhibiting immune checkpointmediated suppression [26] (immune activation)”
Backgroundvan Nierop, G. P., van Luijn, M. M., Michels, S. S., Melief, M.-J., Janssen, M., Langerak, A. W., Ouwendijk, W. J. D., Hintzen, R. Q., & Verjans, G. M. G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1744-4 · Cited by 174
Metadata
- Authors
- Joller, N., Peters, A., Anderson, A. C., & Kuchroo, V. K.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2012-06-21
- Volume
- 248
- Issue
- 1
- Pages
- 122-139
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1584051973
- Cited by
- 106
- References
- 35
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immune checkpoints in central nervous system autoimmunity. https://app.cochat.ai/papers/10.1111/j.1600-065x.2012.01136.x
- The paper
- Joller, N., Peters, A., Anderson, A. C., & Kuchroo, V. K. (2012). Immune checkpoints in central nervous system autoimmunity. Immunological Reviews. https://doi.org/10.1111/j.1600-065x.2012.01136.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.